|Doctor Jared Baeten, MD, PhD
Dr. Baeten is Vice Chair and Professor in the Department of Global Health at the University of Washington. His research focuses on the prevention of HIV-1 and other sexually transmitted diseases, including clinical trials of novel prevention interventions, epidemiologic studies of risk factors for HIV-1 transmission, and biobehavioral and implementation science research aimed at optimizing prevention delivery. He led the Partners PrEP Study and MTN-020/ASPIRE, randomized clinical trials the proved the efficacy of tenofovir-based pills and the dapivirine vaginal ring as pre-exposure prophylaxis (PrEP) against HIV-1 acquisition. Other work includes implementation science projects to deliver antiretroviral treatment and PrEP for HIV-1 prevention and studies exploring use of hormonal contraception as a risk factor for HIV-1
Lisa Bastian has been the Program Manager of the Western Australian Department of Health’s Sexual Health and Blood-borne Virus Program since 2005 and was recently appointed as Manager of the WA HIV Case Management Program. Lisa is responsible for planning and monitoring the HIV policy and public health response in Western Australia. She worked in Aboriginal primary health care and sexual health programs in rural and remote areas in Western Australia for 8 years before working in public health. She is also a member of the Australian Health Protection Principal Committee’s Blood-borne Viruses and Sexually Transmissible Infections Subcommittee. She regularly represents the WA Department of Health at national and state-level policy forums.
Doctor Valerie Delpech
Associate Professor Valerie Delpech is a public health consultant based at Public Health England and leads the national surveillance and monitoring of HIV infections and people in HIV care. She trained in medicine and public health in Australia and has worked in communicable diseases control and prevention for over two decades. Valerie is a honorary associate professor at the University College London. Her research interests have focused on better understanding the dynamics of HIV and other STI epidemics and their impact on vulnerable communities. She is a member of research consortia and an expert advisor on national and international committees in relation to HIV surveillance, prevention, and policy and guideline development. Valerie led the writing of the European HIV testing guidelines and chairs the European HIV Testing Week working group. She is an executive trustee for the National AIDS Trust.
Doctor Joseph Doyle
Dr Doyle is a specialist in infectious diseases and public health medicine, and works at the intersection between clinical medicine, implementation research and health policy. He has particular research interests in epidemiology, prevention and management of blood-borne viruses. He leads a clinical and implementation research program across The Alfred Hospital, Monash University and Burnet Institute to improve treatment access and delivery of hepatitis C treatment. He is currently the co-principal investigator of the HIV/HCV co-infection Eliminate Hepatitis C (co-EC) Study and chief investigator of the NHMRC Eliminate Hepatitis C (EC) Partnership.
He has been an advisor and consultant to the World Health Organisation (WHO) on HIV and viral hepatitis, and led the evidence reviews for first Global WHO guidelines on hepatitis C screening, care and treatment.
Amber D’Souza is an Associate Professor Epidemiology at the Johns Hopkins Bloomberg School of Public Health. Dr. D’Souza leads a research program on infectious causes of cancer, focusing on understudied areas such as anal cancer among MSM, and oral HPV causing tonsillar cancers. She is the co-PI of the datacenter for the Multicenter AIDS Cohort Study (MACS).
|Doctor Angela Kelly-Hanku
Angela currently heads the Sexual and Reproductive Health Unit at the Papua New Guinea Institute of Medical Research. Angela also holds an appointment in the Public Health Intervention Research Group at the Kirby Institute, UNSW. Angela and her team works closely with the PNG National Department of Health and other in country partner to provide an evidence based response for effective and locally appropriate HIV, sexual and reproductive health policy, programming and health advocacy primarily PNG, but with wider relevance and application to the region.
At present Angela is leading PNG's first Key Population Integrated Bio-Behavioural Survey which includes the use of GeneXpert point of care testing for HIV Viral Load, STIs (genital and anorectal) and TB and is currently being implemented in three major sites.
Cindy Liu, M.D., M.P.H., Ph.D., is an Assistant Research Professor in the Department of Environmental and Occupational Health at the George Washington Milken Institute School of Public Health.
The translational goals of her work are to advance our understanding of the role of the microbiome in modifying host susceptibility to pathogens such as HIV, with the goal of leveraging this knowledge to develop novel microbiome-based preventive strategies. Her other research focuses on reducing antibiotic-resistant infections through improving antimicrobial stewardship and the development of rapid diagnostics. Cindy has published more than 30 peer-reviewed manuscripts and she was one of the 2016 ICAAC Young Investigator Award recipients from the American Society for Microbiology.
Cindy completed her residency in Clinical Pathology at Johns Hopkins. She received her medical degree from New York University School of Medicine. She also holds a Doctorate of Philosophy in Biology from Northern Arizona University, a Masters in Public Health from The Johns Hopkins Bloomberg School of Public Health, and Bachelor of Arts in International Studies from The Johns Hopkins University.
|Professor John Murray
John Murray is a Professor of Applied Mathematics at UNSW working mainly in applications of mathematics to biology. Largely that focus has been on mathematical modelling of the in vivo dynamics of viral infections, particularly HIV and hepatitis B virus. One of those projects has been to assess the likely impact of HIV gene therapy, originally with Johnson & Johnson Research and now with Calimmune. Recent work has also investigated the spread of disease within a community, assessing the impact of various interventions against HIV in Papua New Guinea. A current project is centred around the epidemiology of lung cancer in Australia.
|Doctor Kedar Narayan
Kedar Narayan is a group leader at the recently opened Center for Molecular Microscopy (CMM) at the Frederick National Laboratory for Cancer Research. Kedar completed his Natural Sciences Tripos from the University of Cambridge, and PhD in Immunology from The Johns Hopkins School of Medicine. At his post-doc at the laboratory of Sriram Subramaniam at NIH, Kedar developed Focused Ion Beam Scanning Electron Microscopy (FIB-SEM) as a high-resolution electron microscopic tool to study HIV-cell interactions, as well as an enabler for chemical imaging. At the CMM, Kedar continues to work with industry partners to develop FIB-SEM applications in biology. In parallel, he collaborates extensively with NIH and other scientists to use nanoscale 3D electron microscopy to investigate various aspects of structural cell biology in health and disease.